Omabit
Omabit

Omabit

DR1Ahrefs DR: 1/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Speed90Site Speed: 90/100. Top 25%. Measured by Google PageSpeed. Median 62.Trust56Data Trust: 56/100. Below median. Measured by StartupHub.ai. Median 61.

AI for life science R&D, turning R&D data into answers for pharma and biotech teams.

2025ActivePalo Alto, United States

About

Omabit provides an AI-driven platform for life science R&D, enabling biologists and researchers to upload sequencing files and receive structured, reproducible genomic analysis results without writing code. The platform analyzes clinical, genomic, and other R&D data, checks findings against published research, and generates write-ups with the underlying code. It is used by pharma and biotech teams, from the lab to Phase 2 trials, to accelerate analysis from months to days.

Key facts

Website
omabit.com
Headquarters
Palo Alto, United States
Founded
2025
Total funding
$2M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Omabit
DateRoundAmountLead investors
27 Oct 2026Seed$2M

Tech stack

Detected on omabit.com, last scanned 27 Oct 2026.

Compliance
SOC 2
CDN
Cloudflare
Email provider
Google Workspace

Omabit scores 1. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Omabit trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Omabit is 56 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Omabit raised?

Omabit has raised a total of $2M in funding. The most recent round on record is Seed.